Clinical Trial Update: The Sahlgrenska Anti-VEGF Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on an anti-VEGF therapy for age-related macular degeneration; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Unspecified anti-VEGF therapy

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Neovascular Age-related Macular Degeneration | Phase 2 | Status: ACTIVE_NOT_RECRUITING